March 25, 2023
MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update
Patient enrollment underway in Europe in ongoing Phase 2 trial in NSCLC (THIO-101) Outlined plan to initiate second Phase 2…
Pharmaceuticals, Biotechnology and Life Sciences
Patient enrollment underway in Europe in ongoing Phase 2 trial in NSCLC (THIO-101) Outlined plan to initiate second Phase 2…
LOS GATOS, Calif. & SAN FRANCISCO–(BUSINESS WIRE)–#AcceleratedSalesExecution–The Sales Ops Group, the sales strategy and transformation consulting company that accelerates the…
QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation,…
Financing focused on domestic biomanufacturing capacity and capabilities for biologics, vaccines, and nucleic acids SAN DIEGO–(BUSINESS WIRE)–#biomanufacturing–National Resilience, Inc. (Resilience),…
SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces enrollment of the…
DUBLIN–(BUSINESS WIRE)–The “Global Markets for Bioengineered Protein Drugs” report has been added to ResearchAndMarkets.com’s offering. The global bioengineered protein drugs…
THE WOODLANDS, Texas & SANTA ANA, Calif.–(BUSINESS WIRE)–Graf Acquisition Corp. IV (NYSE: GFOR) (“Graf”), a NYSE-listed special purpose acquisition company…
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science…
2022 and Recent Highlights: Full-year 2022 revenues of $88.6 million, up 22% over full-year 2021 revenues of $72.5 million Sold…
RUBY-3, a basket study of povetacicept in autoimmune glomerulonephritis, has initiated patient enrollment; RUBY-4, a basket study of povetacicept in…